Scandinavian Medical Solutions A/S (CPH:SMSMED)
Denmark · Delayed Price · Currency is DKK 3.810
+0.160 (4.38%)
At close: Dec 5, 2025
CPH:SMSMED Revenue
In the fiscal year ending September 30, 2025, Scandinavian Medical Solutions had annual revenue of 245.44M DKK with 8.28% growth. Scandinavian Medical Solutions had revenue of 122.69M in the half year ending September 30, 2025, with 29.22% growth.
Revenue
245.44M
Revenue Growth
+8.28%
P/S Ratio
0.43
Revenue / Employee
8.46M
Employees
29
Market Cap
105.49M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 245.44M | 18.76M | 8.28% |
| Sep 30, 2024 | 226.68M | 35.49M | 18.56% |
| Sep 30, 2023 | 191.19M | 80.66M | 72.98% |
| Sep 30, 2022 | 110.53M | 38.89M | 54.29% |
| Sep 30, 2021 | 71.64M | 29.69M | 70.78% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 315.60B |
| Coloplast | 27.87B |
| Genmab | 24.48B |
| H. Lundbeck | 24.08B |
| Demant | 22.59B |
| GN Store Nord | 17.12B |
| Zealand Pharma | 9.16B |
| Bavarian Nordic | 6.89B |